Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The duration of peptide therapy depends on the specific peptide and the treatment goal
Long-term safety data in humans is limited since it's used as a research compound
The Science Behind Retatrutide's Triple Mechanism Each of retatrutide's three receptor targets contributes unique metabolic benefits: GIP Receptor Activation: Enhances insulin secretion in response to food intake Influences fat metabolism and storage patterns Modulates bone metabolism and cardiovascular function Complements GLP-1 effects for improved glycemic control GLP-1 Receptor Activation: Stimulates insulin release while suppressing glucagon Slows gastric emptying to extend satiety Reduces appetite through central nervous system pathways Provides cardiovascular protective effects Glucagon Receptor Activation: Increases energy expenditure and metabolic rate Promotes fat oxidation and lipolysis Helps prevent metabolic adaptation during weight loss Balances the anabolic effects of insulin signaling This triple-action approach explains why retatrutide demonstrated remarkable results in phase 2 clinical trials, with participants experiencing up to 24.2% body weight reduction at 48 weeks [4]
Clinical measurements using cutometer analysis revealed a 70% increase in skin elasticity after 12 weeks of GHK-Cu application
However, GR also is involved in increasing blood glucose (Undesirable in diabetic patients), meaning this needs to be offset by corresponding decreases in blood glucose via GLP1R
Basel, Switzerland: 185
